Hi Sydney Cloud,I was only going off Comsec's report from last year, so book value could be significantly different now.And yes, MIX is another gem in my opinion.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%